Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada.
J Clin Invest. 2018 Aug 1;128(8):3228-3230. doi: 10.1172/JCI121744. Epub 2018 Jul 9.
Langerhans cells (LCs) are likely among the first targets of HIV-1 infection due to their localization in mucosal tissues. In their recent work, Pena-Cruz and colleagues were able to study HIV-1 infection in vaginal epithelial DCs (VEDCs), termed CD1a+ VEDCs. They show that VEDCs are distinct from other blood- and tissue-derived DCs or LCs because they express the protein langerin but not the lectin receptor DC-SIGN, and they do not have Birbeck granules. The results from this study indicate that HIV-1 using CXCR4 replicates poorly in VEDCs but that a higher replication for HIV-1 using CCR5 strains is supported by VDECs. Furthermore, Pena-Cruz and colleagues demonstrate that VDECs can represent a viral reservoir in HIV-1-infected virologically suppressed women. As such, VDECs may represent another sanctuary of viral persistence and can be an additional obstacle to viral eradication.
郎格汉斯细胞(LCs)因其位于黏膜组织中,可能是 HIV-1 感染的首批目标之一。在他们最近的工作中,Pena-Cruz 及其同事成功研究了阴道上皮树突状细胞(VEDC)中 HIV-1 的感染,将其称为 CD1a+ VEDC。他们发现,与其他血液和组织来源的树突状细胞或 LCs 不同,VEDC 表达蛋白 langerin,但不表达凝集素受体 DC-SIGN,并且没有 Birbeck 颗粒。这项研究的结果表明,使用 CXCR4 的 HIV-1 在 VEDC 中的复制能力较差,但 VEDC 支持使用 CCR5 株的 HIV-1 更高的复制率。此外,Pena-Cruz 及其同事证明,VEDC 可以作为 HIV-1 感染的病毒库,在病毒学上抑制的女性中。因此,VEDC 可能代表病毒持续存在的另一个避难所,并可能成为病毒根除的另一个障碍。